Prospective Screening for Pancreatic Ductal Adenocarcinoma in High-Risk Individuals

Clinical trial NCT06122896 · RECRUITING

Trial details

NCT number: NCT06122896
Sponsor: Dana-Farber Cancer Institute
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Pancreatic Cancer Pancreatic Ductal Adenocarcinoma PDAC PDAC - Pancreatic Ductal Adenocarcinoma Pancreatic Neoplasm

Start date: 2023-11-21
Primary completion: 2040-10-31
Enrollment: 5000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.